MED
Medifast Inc

1,805
Loading...
Loading...
News
all
press releases
Will Medifast's Strategic Endeavors Deliver Growth in 2025?
MED boosts growth efforts with new products, digital tools and an expanded OPTAVIA coaching network.
Zacks·7d ago
News Placeholder
More News
News Placeholder
Medifast (MED) Up 6.5% Since Last Earnings Report: Can It Continue?
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·23d ago
News Placeholder
HIMS' Personalized Wellness Platform Expands Preventive Care Access
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
Zacks·24d ago
News Placeholder
Medifast Bolsters Growth Through Health & Wellness Solutions
MED is expanding OPTAVIA, digital tools and wellness offerings to drive long-term growth and strengthen customer ties.
Zacks·1mo ago
News Placeholder
Hims & Hers Redefines Virtual Care With Integrated Tech Platforms
HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.
Zacks·2mo ago
News Placeholder
Medifast's Q2 Earnings Beat Estimates, Lower Revenues Hurt Margins
MED's second-quarter 2025 earnings and sales decline as active earning OPTAVIA coaches dipped, hit by client acquisition.
Zacks·2mo ago
News Placeholder
Clorox Q4 Earnings Beat Estimates, Organic Sales Increase Y/Y
CLX posts 57.7% EPS growth and 8% organic sales gain in the fourth quarter, fueled by strong ERP-driven volume increases.
Zacks·2mo ago
News Placeholder
Kraft Heinz Q2 Earnings Beat Estimates, Organic Sales Down 2% Y/Y
KHC tops Q2 estimates despite declines in earnings and organic sales, as pricing gains fail to offset weak volumes.
Zacks·2mo ago
News Placeholder
Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness
HIMS is transforming digital wellness with personalized care, over 30 million telehealth consultations, and a Gen Z-aligned platform.
Zacks·3mo ago
News Placeholder
Mondelez (MDLZ) Down 2.2% Since Last Earnings Report: Can It Rebound?
Zacks·4mo ago

Latest MED News

View

Advertisement|Remove ads.

Advertisement|Remove ads.